As the previous segment points out, these procedures are durable, rapidly, relatively affordable, and reasonably convenient to use, earning them desirable to regulators enthusiastic about monitoring drug quality. Box 6-3 describes the Chinese regulatory authority's cellular verification labs. Deal verification technologies may also assist in subjec